Global Downstream Processing Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2027
“Global Downstream Processing Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global downstream processing market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global downstream processing market report has been segmented on the basis of technique, product, application, end user, and region.
Downstream processing is a purification and recovery process for biosynthetic products, primarily pharmaceuticals from the natural sources such as animal tissues, fermentation broth, or plant tissues. It is an important phase in production of pharmaceutical products such as hormones (e.g. human growth hormone and insulin), antibodies (e.g. abciximab and infliximab) and antibiotics, vaccines, enzymes antibodies used in diagnostics, natural and flavor fragrance compounds, and industrial enzymes.
In addition, downstream processing involves five stages such as intracellular products are released, solid-liquid separation, concentration, chromatography method is utilized for formulation and purification. Solid-liquid separation process includes methods such as flocculation, centrifugation, filtration, and flotation.
Increasing demand for downstream processing across various end-use applications including monoclonal antibody production, vaccine production, and insulin production is a major factor estimated to drive growth of the target market over the next 10 years. In addition, increasing R&D expenditure in biopharmaceutical companies and increasing demand for biopharmaceuticals are other key factors estimated to support revenue growth of the target market over the next 10 years.
In addition, developments in field of genetic engineering and gene therapy is another factor expected to drive growth of the target market over the forecast period.
However, high cost of instruments is a major factor estimated to hamper growth of the target market to certain extent.
On the basis of technique, purification segment is expected to dominate the global downstream processing market. The purification segment revenue is anticipated to register highest CAGR over the forecast.
On the basis of application, the vaccine production segment is expected to account for significant share in terms of revenue in the target market. The vaccine production segment revenue is also projected to register highest CAGR over the forecast.
On the basis of end user, the biopharmaceutical manufacturers segment is expected to account for major share in terms of revenue in the global market. The biopharmaceutical manufacturers segment revenue is also anticipated to register highest CAGR over the forecast.
North America downstream processing market is estimated to account for major share in terms of revenue in the target market. The Asia Pacific market is projected to register fastest growth in terms of revenue over the next 10 years, owing to increasing demand from monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, and erythropoietin production industry in the countries in region.
Global downstream processing market segmentation:
Segmentation by technique:
- Solid-liquid Separation
Segmentation by product:
- Chromatography Columns and Resins
- Membrane Adsorbers
- Single-use Products
- Other Products (Consumables and Accessories)
Segmentation by application:
- Monoclonal Antibody Production
- Vaccine Production
- Insulin Production
- Immunoglobulin Production
- Erythropoietin Production
- Other Applications (Growth Hormones, Blood Coagulation Factors, Interferons, Fusion Proteins, Anticoagulants, Anti-bacterial (Antibiotics), Medical Enzymes, and Colony Stimulating Factors)
Segmentation by end user:
- Biopharmaceutical Manufacturers
- Contract Manufacturing Organizations (CMOs)
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Thermo Fisher Scientific Inc.
- GE Healthcare Inc.
- Sartorius Stedim Biotech S.A.
- Merck Millipore Limited
- Danaher Corporation
- 3M Company
- Boehringer Ingelheim GmbH
- Lonza Group Ltd.
- Eppendorf AG
- Finesse Solutions, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!